ISSN 2515-8260
 

Research Article 


Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study

Mazin Adday Hasoon.

Abstract
Background: Nocturia is night waking for voiding, is a lower urinary tract problem of anxious symptom. nocturnal polyuria, diminished capacity of the bladder either nocturnal and/or global capacity, and sleep impairment are main pathophysiologic subtypes. fluid restriction mainly awhile before the bed time, anticholinergic therapy, diuretics and hormone replacement therapy are main preventive strategies.
Aim of Study: To determine the oral desmopressin efficacy and safety of in nocturia of women as a treatment.
Patients and methods: - Sixty-four women with18-80 years’ age with nocturia (nocturia index score >1, more than two voids per night) were invited to attend our study. randomly assigned patients into: 32 women received different desmopressin doses (0.2, 0.4, or 0.6 mg) during dose-titration period(three-weeks), and the other 32 ones received single- blind placebo treatment for 6 or 8 weeks according to their response.
Results: In single-blind phase, for desmopressin, 30 (93.75 %) patients with fifty percent or more nocturnal voids reduction against the baseline levels in comparison to only 3 (9.7%)placebo-receiving patients where (P < 0.001). The mean nocturnal voids No., sleep period till 1st nocturnal void, nocturnal diuresis, and allover day volumes changed signscantly preferring desmopressin. (P<0.001).
Conclusions: women with nocturia better to be treated with oral desmopressin and informed about tolerance and effectiveness.

Key words: Desmopressin efficacy; nocturic women; A single-blind placebo.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mazin Adday Hasoon
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Mazin Adday Hasoon. Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study. EJMCM. 2020; 7(1): 51-58.


Web Style

Mazin Adday Hasoon. Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study. http://www.ejmcm.com/?mno=102010 [Access: July 15, 2020].


AMA (American Medical Association) Style

Mazin Adday Hasoon. Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study. EJMCM. 2020; 7(1): 51-58.



Vancouver/ICMJE Style

Mazin Adday Hasoon. Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study. EJMCM. (2020), [cited July 15, 2020]; 7(1): 51-58.



Harvard Style

Mazin Adday Hasoon (2020) Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study. EJMCM, 7 (1), 51-58.



Turabian Style

Mazin Adday Hasoon. 2020. Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study. European Journal of Molecular & Clinical Medicine, 7 (1), 51-58.



Chicago Style

Mazin Adday Hasoon. "Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study." European Journal of Molecular & Clinical Medicine 7 (2020), 51-58.



MLA (The Modern Language Association) Style

Mazin Adday Hasoon. "Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study." European Journal of Molecular & Clinical Medicine 7.1 (2020), 51-58. Print.



APA (American Psychological Association) Style

Mazin Adday Hasoon (2020) Desmopressin Efficacy in Treatment of Nocturic Women- A Single-Blind Placebo-Controlled Study. European Journal of Molecular & Clinical Medicine, 7 (1), 51-58.